Evidence map›Paper›PMID 36205169›Full record

ArticleEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin2022

Very low risk of monkeypox among staff and students after exposure to a confirmed case in educational settings, England, May to July 2022.

Shamez N Ladhani, Felicity Aiano, David S Edwards, Samantha Perkins, Wazirzada M Khan, Nalini Iyanger, Elizabeth Whittaker, Jonathan M Cohen, David Ho, Susan Hopkins and 2 more

Open access · diamondAbstract read
In one paragraph

Article in Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 3 pooled it
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 3 syntheses or guidelines pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Mpox in children and adolescents and contact follow-up in school settings in greater Paris, France, May 2022 to July 2023.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2024
    Article
  5. Observational
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Shamez N LadhaniImmunisation Division, UK Health Security Agency, London, United Kingdom.
Felicity AianoImmunisation Division, UK Health Security Agency, London, United Kingdom.
David S EdwardsUK Health Security Agency East of England Health Protection Team, Mildenhall, United Kingdom.
Samantha PerkinsUK Health Security Agency, South London Health Protection Team and the London Coordination and Response Cell, London, United Kingdom.
Wazirzada M KhanUK Health Security Agency, South London Health Protection Team and the London Coordination and Response Cell, London, United Kingdom.
Nalini IyangerUK Health Security Agency Northwest London Health Protection Team and the London Coordination and Response Cell, London, United Kingdom.
Elizabeth WhittakerPaediatric Infectious Diseases Department, Imperial College London, London, United Kingdom.
Jonathan M CohenPaediatric Immunology and Infectious Diseases, Evelina London Children's Hospital, London, United Kingdom.
David HoPaediatric Immunology and Infectious Diseases, Evelina London Children's Hospital, London, United Kingdom.
Susan HopkinsClinical and Public Health Group, UK Health Security Agency, London, United Kingdom.
Mary E RamsayImmunisation Division, UK Health Security Agency, London, United Kingdom.
J Yimmy ChowUK Health Security Agency Northwest London Health Protection Team and the London Coordination and Response Cell, London, United Kingdom.
UK Health Security AgencyEvelina London Children's Healthcare · GBImperial College London · GBSt George's, University of London · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We investigated a secondary school (11-16 year-olds), a primary school (5-11 year-olds), reception year (4-5 year-olds) and a nursery (2-5 year-olds) following confirmed monkeypox in an adult in each educational setting during June and July 2022. MVA-BN vaccine was offered up to 14 days post exposure to 186 children < 12 years and 21 were vaccinated. No secondary cases occurred among at least 340 exposed students and more than 100 exposed staff during the 28-day follow-up period.

Indexed as

Mpox, MonkeypoxAdultChildEnglandHumansSchoolsStudentsexposuremonkeypoxoutbreakschoolvaccine

Identifiers

PMID36205169
PMCPMC9540521
OpenAlexW4303415523

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.